| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |